Urotensin II, from fish to human

Annals of the New York Academy of Sciences

Volumn 1200, Issue , 2010, Pages 53-66

  Vaudry, Hubert ^a,b,c   Do Rego, Jean Claude ^a   Le Mevel, Jean Claude ^d   Chatenet, David ^a,c,e   Tostivint, Hervé ^a,f   Fournier, Alain ^c,e   Tonon, Marie Christine ^a,b,c   Pelletier, Georges ^g   Michael Conlon, J ^h   Leprince, Jérôme ^a,b,c  

^a UNIVERSITÉ DE ROUEN   (France)

^b Platform for Cell Imaging of Normandy   (France)

^c International Associated Laboratory Samuel de Champlain   (France)

^d UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^e INRS INSTITUT ARMAND FRAPPIER   (Canada)

^f CNRS   (France)

^g LAVAL UNIVERSITY   (Canada)

^h UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

behavioral effects; cardiovascular system; evolution; urotensin II; URP; UT

Indexed keywords

UROTENSIN II;

AMPHIBIA; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING ORGAN SYSTEMS; BRAIN STEM; CARDIOVASCULAR FUNCTION; CONFERENCE PAPER; ENDOCRINE FUNCTION; FISH; HORMONE ACTION; HUMAN; IMMUNE FUNCTION; KIDNEY FUNCTION; MAMMAL; NONHUMAN; PROTEIN ANALYSIS; REGULATORY MECHANISM; SPINAL CORD;

EID: 77954581188     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05514.x     Document Type: Conference Paper

References (140)

1. Zelnik, P.R. K. Lederis. 1973. Chromatographic separation of urotensins. Gen. Comp. Endocrinol. 20 : 392 400.
2. Chan, D.K.O. H.A. Bern. 1976. The caudal neurosecretory system. Cell Tissue Res. 174 : 339 354.
3. Ichikawa, T. 1978. Acetylcholine in the urophysis of several species of teleosts. Gen. Comp. Endocrinol. 35 : 226 233.
4. Lederis, K., A. Letter, D. McMaster, et al. 1982. Complete amino acid sequence of urotensin I, a hypotensive and corticotrophin-releasing neuropeptide from catostomus. Science 218 : 162 164. (Pubitemid 12024631)
5. Pearson, D., J.E. Shively, B.R. Clark, et al. 1980. Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc. Natl. Acad. Sci. USA 77 : 5021 5024.
6. Lacanilao, F. 1972. The urophysial hydroosmotic factor of fishes. II. Chromatographic and pharmacologic indication of similarity to arginine vasopressin. Gen. Comp. Endocrinol. 14 : 413 420.
7. Yulis, C.R. K. Lederis. 1986. Extraurophyseal distribution of urotensin II immunoreactive neuronal perikarya and their process. Proc. Natl. Acad. Sci. USA 83 : 7079 7083.
8. Yulis, C.R. K. Lederis. 1988. Occurrence of an anterior spinal, cerebrospinal fluid-contacting, urotensin II neuronal system in various fish species. Gen. Comp. Endocrinol. 70 : 301 311.
9. Gonzalez, G.C., M. Martinez-Padron, K. Lederis K. Lukowiak. 1992. Distribution and coexistence of urotensin I and urotensin II peptides in the cerebral ganglia of Aplysia californica. Peptides 13 : 695 703.
10. Waugh, D. J.M. Conlon. 1993. Purification and characterization of urotensin II from the brain of a teleost (trout, Oncorhynchus mykiss) and an elasmobranch (skate, Raja rhina). Gen. Comp. Endocrinol. 92 : 419 427.
11. Itoh, H., D. McMaster K. Lederis. 1988. Functional receptors for fish neuropeptide urotensin II in major rat arteries. Eur. J. Pharmacol. 149 : 61 66.
12. Gibson, A., H.A. Bern, M. Ginsburg, et al. 1984. Neuropeptide-induced contraction and relaxation of the mouse anococcygeus muscle. Proc. Natl. Acad. Sci. USA 81 : 625 629.
13. Gibson, A. 1987. Complex effects of Gillichthys urotensin II on rat aortic strips. Br. J. Pharmacol. 91 : 205 212.
14. Gibson, A., P. Wallace H.A. Bern. 1986. Cardiovascular effects of urotensin II in anesthetized and pithed rats. Gen. Comp. Endocrinol. 64 : 435 439.
15. Conlon, J.M. 2008. "Liberation" of urotensin II from the teleost urophysis: an historical overview. Peptides 29 : 651 657.
16. Chartrel, N., J.M. Conlon, J.M. Danger, et al. 1991. Characterization of melanotropin release-inhibiting factor (melanostatin) from frog brain: homology with human neuropeptide Y. Proc. Natl. Acad. Sci. USA 88 : 3862 3866.
17. Chartrel, N., M.C. Tonon, H. Vaudry, et al. 1991. Primary structure of frog pituitary adenylate cyclase-activating polypeptide (PACAP) and effects of ovine PACAP on frog pituitary. Endocrinology 129 : 3367 3371.
18. Conlon, J.M., F. O'Harte, D.D. Smith, et al. 1992. Isolation and primary structure of urotensin II from the brain of a tetrapod, the frog Rana ridibunda. Biochem. Biophys. Res. Commun. 188 : 578 583.
19. Coulouarn, Y., I. Lihrmann, S. Jégou, et al. 1998. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc. Natl. Acad. Sci. USA 95 : 15803 15808.
20. Ames, R.S., H.M. Sarau, J.K. Chambers, et al. 1999. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401 : 282 286.
21. Elshourbagy, N.A., S.A. Douglas, U. Shabon, et al. 2002. Molecular and pharmacological characterization of genes encoding urotensin II-related peptides and their cognate G-protein-coupled receptors from the mouse and monkey. Br. J. Pharmacol. 136 : 9 22.
22. Mori, M., T. Sugo, M. Abe, et al. 1999. Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14). Biochem. Biophys. Res. Commun. 265 : 123 129.
23. Coulouarn, Y., S. Jégou, H. Tostivint, et al. 1999. Cloning, sequence analysis and tissue distribution of the mouse and the rat urotensin II precursors. FEBS Lett. 457 : 28 32.
24. Tostivint, H., L. Joly, I. Lihrmann, et al. 2006. Comparative genomics provides evidence for close evolutionary relationships between the urotensin II and somatostatin gene families. Proc. Natl. Acad. Sci. USA 103 : 2237 2242.
25. Chartrel, N., J.M. Conlon, F. Collin, et al. 1996. Urotensin II in the central nervous system of the frog Rana ridibunda: immunohistochemical localization and biochemical characterization. J. Comp. Neurol. 364 : 324 339.
26. Coulouarn, Y., C. Fernex, S. Jégou, et al. 2001. Specific expression of the urotensin II gene in sacral motoneurons of developing rat spinal cord. Mech. Dev. 101 : 187 190.
27. Dun, S.L., G.C. Brailoiu, J. Yang, et al. 2001. Urotensin II-immunoreactivity in the brainstem and spinal cord of the rat. Neurosci. Lett. 305 : 9 12.
28. Chartrel, N., J. Leprince, C. Dujardin, et al. 2004. Biochemical characterization and immunohistochemical localization of urotensin II in the human brainstem and spinal cord. J. Neurochem. 91 : 110 118.
29. Dubessy, C., D. Cartier, B. Lectez, et al. 2008. Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction. J. Neurochem. 107 : 361 374.
30. Pelletier, G., I. Lihrmann H. Vaudry. 2002. Role of androgens in the regulation of urotensin II precursor mRNA expression in the rat brainstem and spinal cord. Neuroscience 115 : 525 532.
31. Tal, M., D.A. Ammar, M. Karpuj, et al. 1995. A novel putative neuropeptide receptor expressed in neural tissue, including sensory epithelia. Biochem. Biophys. Res. Commun. 209 : 752 759.
32. Marchese, A., M. Heiber, T. Nguyen, et al. 1995. Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors. Genomics 29 : 335 344.
33. Liu, Q., S.S. Pong, Z. Zeng, et al. 1999. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem. Biophys. Res. Commun. 266 : 174 178.
34. Nothacker, H.P., Z. Wang, A.M. McNeill, et al. 1999. Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction. Nat. Cell Biol. 1 : 383 385.
35. Matsushita, M., M. Shichiri, T. Imai, et al. 2001. Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J. Hypertens. 19 : 2185 2190.
36. Totsune, K., K. Takahashi, Z. Arihara, et al. 2001. Role of urotensin II in patients on dialysis. Lancet 359 : 810 811.
37. Maguire, J.J., R.E. Kuc, M.J. Kleinz A.P. Davenport. 2008. Immunocytochemical localization of the urotensin-II receptor, UT, in rat and human tissues: relevance to function. Peptides 29 : 735 742.
38. Clark, S.D., H.P. Nothacker, Z. Wang, et al. 2001. The urotensin II receptor is expressed in the cholinergic mesopontine tegmentum of the rat. Brain Res. 923 : 120 127.
39. Jégou, S., D. Cartier, C. Dubessy, et al. 2006. Localization of the urotensin-II receptor in the rat central nervous system. J. Comp. Neurol. 495 : 21 36.
40. Lin, Y., T. Tsuchihashi, K. Matsumura, et al. 2003. Central cardiovascular action of urotensin II in spontaneously hypertensive rats. Hypertens. Res. 26 : 839 845. (Pubitemid 37406953)
41. Rossowski, W.J., B.L. Cheng, J.E. Taylor, et al. 2002. Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases, and Rho-kinase: inhibition by somatostatin receptor antagonists. Eur. J. Pharmacol. 438 : 159 170.
42. Saetrum Opgaard, O., H. Nothacker, F.J. Ehlert, et al. 2000. Human urotensin II mediates vasoconstriction via an increase in inositol phosphates. Eur. J. Pharmacol. 406 : 265 271.
43. Castel, H., M. Diallo, D. Chatenet, et al. 2006. Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes. J. Neurochem. 99 : 582 595.
44. Gibson, A., S. Conyers, H.A. Bern, et al. 1988. The influence of urotensin II on calcium flux in rat aorta. J. Pharm. Pharmacol. 40 : 893 895.
45. Yano, K., J.W. Hicks, H. Vaudry, et al. 1995. Cardiovascular actions of frog urotensin II in the frog Rana catesbeiana. Gen. Comp. Endocrinol. 97 : 103 110.
46. Ziltener, P., C. Mueller, B. Haenig, et al. 2002. Urotensin II mediates ERK1/2 phosphorylation and proliferation in GPR14-transfected cell lines. J. Recept. Signal Transduct. Res. 22 : 155 168.
47. Katano, Y., A. Ishihata, T. Aita, et al. 2000. Vasodilatator effect of urotensin II, one of the most potent vasoconstricting factors, on rat coronary arteries. Eur. J. Pharmacol. 402 : 209 211.
48. Sauzeau, V., E. Le Mellionnec, J. Bertoglio, et al. 2001. Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ. Res. 88 : 1102 1104.
49. Sugo, T., Y. Murakami, Y. Shimomura, et al. 2003. Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain. Biochem. Biophys. Res. Commun. 310 : 860 868.
50. Labarrère, P., D. Chatenet, J. Leprince, et al. 2003. Structure-activity relationships of human urotensin II and related analogues on rat aortic ring contraction. J. Enz. Inh. Med. Chem. 18 : 77 88.
51. Chatenet, D., C. Dubessy, J. Leprince, et al. 2004. Structure-activity relationships and structural conformation of a novel urotensin II-related peptide. Peptides 25 : 1819 1830.
52. Pelletier, G., I. Lihrmann, C. Dubessy, et al. 2005. Androgenic down-regulation of urotensin II precursor, urotensin II-related peptide precursor and androgen receptor mRNA in the mouse spinal cord. Neuroscience 132 : 689 696.
53. Malagon, M.M., M. Molina, M.D. Gahete, et al. 2008. Urotensin II and urotensin II-related peptide activate somatostatin receptor subtype 2 and 5. Peptides 29 : 711 720.
54. Carotenuto, A., P. Grieco, P. Campiglia, et al. 2004. Unraveling the active conformation of urotensin II. J. Med. Chem. 47 : 1652 1661.
55. Boivin, S., L. Guilhaudis, I. Milazzo, et al. 2006. Characterization of urotensin II receptor structural domains involved in the recognition of UII, URP, and urantide. Biochemistry 45 : 5993 6002.
56. Boivin, S., I. Ségalas-Milazzo, L. Guilhaudis, et al. 2008. Solution structure of urotensin-II receptor extracellular loop III and characterization of its interaction with urotensin-II. Peptides 29 : 700 710.
57. Perkins, T.D.J., S. Bansal D.J. Barlow. 1990. Molecular modelling and design of analogues of the peptide hormone urotensin II. Biochem. Soc. Trans. 18 : 918 919.
58. Flohr, S., M. Kurz, E. Kostenis, et al. 2002. Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II. J. Med. Chem. 45 : 1799 1805.
59. Kinney, W.A., H.R. Almond, J. Qi, et al. 2002. Structure-function analysis of urotensin II and its use in the construction of a ligand-receptor working model. Angew. Chem. Int. Ed. 41 : 2940 2944.
60. Brkovic, A., A. Hattenberger, E. Kostenis, et al. 2003. Functional and binding characterizations of urotensin II-related peptides in human and rat urotensin II-receptor assay. J. Pharmacol. Exp. Ther. 306 : 1200 1209.
61. Foister, S., L.L. Taylor, J.-J. Feng, et al. 2006. Design and synthesis of potent cystine-free cyclic hexapeptide agonists at the human urotensin receptor. Org. Lett. 8 : 1799 1802.
62. 9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. Peptides 30 : 1130 1136.
63. Camarda, V., A. Rizzi, G. Calo, et al. 2002. Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents. Naunyn. Schmiedebergs. Arch. Pharmacol. 365 : 141 149.
64. Camarda, V., R. Guerrini, E. Kostenis, et al. 2002. A new ligand for the urotensin II receptor. Br. J. Pharmacol. 137 : 311 314.
65. Vergura, R., V. Camarda, A. Rizzi, et al. 2004. Urotensin II stimulates plasma extravasation in mice via UT receptor activation. Naunyn. Schmiedebergs. Arch. Pharmacol. 370 : 347 352.
66. Patacchini, R., P. Santicioli, S. Giuliani, et al. 2003. Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta. Br. J. Pharmacol. 140 : 1155 1158.
67. Camarda, V., W. Song, E. Marzola, et al. 2004. Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors. Eur. J. Pharmacol. 498 : 83 86.
68. Cheriyan, J., T.J. Burton, T.J. Bradley, et al. 2009. The effects of urotensin II and urantide on forearm blood flow and systemic haemodynamics in humans. Br. J. Clin. Pharmacol. 68 : 518 523.
69. Weiss, J., S.-J. Han, S.-K. Kim, et al. 2008. Conformational changes involved in G-protein-coupled-receptor activation. Trends Pharmacol. Sci. 29 : 616 625.
70. Huynh, J., W.G. Thomas, M.-I. Aguilar, et al. 2009. Role of helix 8 in G protein-coupled receptors based on structure-function studies on the type 1 angiotensin receptor. Mol. Cell. Endocrinol. 302 : 118 127.
71. Bern, H.A. K. Lederis. 1969. A reference preparation for the study of active substances in the caudal neurosecretory system of teleost. J. Endocrinol. 45 : xi-xii.
72. Chan, D.K.O., I. Chester Jones S. Ponniah. 1969. Studies on the pressor substances in the caudal neurosecretory system of teleost fish: bioassay and fractionation. J. Endocrinol. 45 : 151 159.
73. Bern, H.A., D. Pearson, B.A. Larson, et al. 1985. Neurohormones from fish tails: the caudal neurosecretory system. Urophysiology and the caudal neurosecretory system of fishes. Rec. Prog. Horm. Res. 41 : 533 552.
74. Marshall, W.S. H.A. Bern. 1979. Teleostean urophysis: urotensin II and ion transport across the isolated skin of marine teleost. Science 204 : 519 521.
75. Marshall, W.S. H.A. Bern. 1981. Active chloride transport by the skin of marine teleost is stimulated by urotensin I and inhibited by urotensin II. Gen. Comp. Endocrinol. 43 : 484 491.
76. Mainoya, J.R. H.A. Bern. 1982. Effects of teleost urotensins on intestinal absorption of water and NaCl in tilapia, Sarotherodon mossambicus, adapted to fresh water or seawater. Gen. Comp. Endocrinol. 47 : 54 58.
77. Mainoya, J.R. H.A. Bern. 1984. Influence of vasoactive intestinal peptide and urotensin II on the absorption of water and NaCl by the anterior intestine of the Tilapia, Sarotherodon mossambicus. Zool. Sci. 1 : 100 105.
78. Loretz, C.A., R.W. Freel H.A. Bern. 1983. Specificity of response of intestinal ion transport systems to a pair of natural peptide hormone analogs: somatostatin and urotensin II. Gen. Comp. Endocrinol. 52 : 198 206.
79. Loretz, C.A. H.A. Bern. 1981. Stimulation of sodium transport across the teleost urinary bladder by urotensin II. Gen. Comp. Endocrinol. 43 : 325 330.
80. Stenhouse, A.A. R.J. Balment. 1998. Urotensin II stimulates cAMP production in the kidney of seawater-adapted but not freshwater-adapted flounder, Platichthys flesus. Ann. N.Y. Acad. Sci. 839 : 389 391.
81. ++, and adenosine 3′,5′-monophosphate in prolactin release in vitro. Endocrinology 110 : 910 915.
82. Rivas, R.J., R.S. Nishioka H.A. Bern. 1986. in vitro effects of somatostatin and urotensin II on prolactin and growth hormone secretion in tilapia, Oreochromis mossambicus. Gen. Comp. Endocrinol. 63 : 245 251.
83. Arnold Reed D.E. R.J. Balment. 1994. Peptide hormones influence in vitro interrenal secretion of cortisol in the trout, Oncorhynchus mykiss. Gen. Comp. Endocrinol. 96 : 85 91.
84. Kelsall, C.J. R.J. Balment. 1998. Native urotensins influence cortisol secretion and plasma cortisol concentration in the euryhaline flounder, Platichthys flesus. Gen. Comp. Endocrinol. 112 : 210 219.
85. Bond, H., M.J. Winter, J.M. Warne, et al. 2002. Plasma concentrations of arginine vasotocin and urotensin II are reduced following transfer of the euryhaline flounder (Platichthys flesus) from seawater to fresh water. Gen. Comp. Endocrinol. 125 : 113 120.
86. Lu, W., M. Greenwood, L. Dow, et al. 2006. Molecular characterization and expression of urotensin II and its receptor in the flounder (Platichthys flesus): a hormone system supporting body fluid homeostasis in euryhaline fish. Endocrinology 147 : 3692 3708.
87. Le Mevel, J.C., F. Lancien N. Mimassi. 2008. Central and peripheral cardiovascular, ventilatory and motor effects of trout urotensin II in the trout. Peptides 29 : 830 837.
88. Le Mevel, J.C., K.R. Olson, D. Conklin, et al. 1996. Cardiovascular actions of trout urotensin II in the conscious trout, Oncorhynchus mykiss. Am. J. Physiol. 271 : R1335 R1343.
89. Hazon, N., C. Bjenning J.M. Conlon. 1993. Cardiovascular actions of dogfish urotensin II in the dogfish Scyliorhinus canicula. Am. J. Physiol. 265 : R573 R576.
90. Lancien, F., J. Leprince, N. Mimassi, et al. 2004. Central effects of native urotensin II on motor activity, ventilatory movements, and heart rate in the trout Oncorhynchus mykiss. Brain Res. 1023 : 167 174.
91. Lancien, F., J. Leprince, N. Mimassi, et al. 2005. Time-course effects of centrally administered native urotensin-II on motor and cardioventillatory activity in trout. Ann. N.Y. Acad. Sci. 1040 : 371 374.
92. Yano, K., H. Vaudry J.M. Conlon. 1994. Spasmogenic actions of frog urotensin II on the bladder and ileum of the frog, Rana catesbeiana. Gen. Comp. Endocrinol. 96 : 412 419.
93. Do Rego, J.C., J. Leprince, E. Scalbert, et al. 2008. Behavioral actions of urotensin-II. Peptides 29 : 838 844.
94. Gartlon, J., F. Parker, D.C. Harrison, et al. 2001. Central effects of urotensin-II following ICV administration in rats. Psychopharmacology 155 : 426 433.
95. Do Rego, J.C., D. Chatenet, M.H. Orta, et al. 2005. Behavioral effects of urotensin-II centrally administered in mice. Psychopharmacology 183 : 103 117.
96. Matsumoto, Y., M. Abe, T. Watanabe, et al. 2004. Intracerebroventricular administration of urotensin II promotes anxiogenic-like behaviors in rodents. Neurosci. Lett. 358 : 99 102.
97. Quattrochi, J.J., A.N. Mamelak, R.D. Madison, et al. 1989. Mapping neuronal inputs to REM sleep induction sites with carbachol-fluorescent microspheres. Science 245 : 984 986.
98. De Lecea, L. P. Bourgin. 2008. Neuropeptide interactions and REM sleep: a role for urotensin II?Peptides 29 : 845 851.
99. Ono, T., Y. Kawaguchi, M. Kudo, et al. 2008. Urotensin II evokes neurotransmitter release from rat cerebrocortical slices. Neurosci. Lett. 440 : 275 279.
100. Watson, A.M., G.W. Lambert, K.J. Smith C.N. May. 2003. Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions. Hypertension 42 : 373 379.
101. Silvestre, R.A., J. Rodríguez-Gallardo, E.M. Egido J. Marco. 2001. Inhibition of insulin release by urotensin II - a study on the perfused rat pancreas. Horm. Metab. Res. 33 : 379 381.
102. Silvestre, R.A., E.M. Egido, R. Hernández, et al. 2004. Urotensin-II is present in pancreatic extracts and inhibits insulin release in the perfused rat pancreas. Eur. J. Endocrinol. 151 : 803 809.
103. Marco, J., E.M. Egido, R. Hernández R.A. Silvestre. 2007. Evidence for endogenous urotensin-II as an inhibitor of insulin secretion. Study in the perfused rat pancreas. Peptides 29 : 852 858.
104. Silvestre, R.A., E.M. Egido, R. Hernández J. Marco. 2009. Characterization of the insulinostatic effect of urotensin II: a study in the perfused rat pancreas. Regul. Pept. 153 : 37 42.
105. Wang, H.X., X.J. Zeng, Y. Liu, et al. 2009. Elevated expression of urotensin II and its receptor in skeletal muscle of diabetic mouse. Regul. Pept. 154 : 85 90.
106. Totsune, K., K. Takahashi, Z. Arihara, et al. 2003. Increased plasma urotensin II levels in patients with diabetes mellitus. Clin. Sci. 104 : 1 5.
107. Suguro, T., T. Watanabe, S. Kodate, et al. 2008. Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes. Clin. Sci. 115 : 327 334.
108. Wenyi, Z., S. Suzuki, M. Hirai, et al. 2003. Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects. Diabetologia 46 : 972 976.
109. Sidharta, P.N., K. Rave, L. Heinemann, et al. 2009. Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with type 2 diabetes mellitus. Br. J. Clin. Pharmacol. 68 : 502 510.
110. Giuliani, L., L. Lenzini, M. Antonello, et al. 2009. Expression and functional role of urotensin-II and its receptor in the adrenal cortex and medulla: novel insights for the pathophysiology of primary aldosteronism. J. Clin. Endocrinol. Metab. 94 : 684 690.
111. Albertin, G., V. Casale, A. Ziolkowska, et al. 2006. Urotensin-II and UII-receptor expression and function in the rat adrenal cortex. Int. J. Mol. Med. 17 : 1111 1115.
112. Maguire, J.J., R.E. Kuc A.P. Davenport. 2000. Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br. J. Pharmacol. 131 : 441 446.
113. Bottrill, F.E., S.A. Douglas, C.R. Hiley R. White. 2000. Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries. Br. J. Pharmacol. 130 : 1865 1870.
114. Douglas, S.A., A.C. Sulpizio, V. Piercy, et al. 2000. Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey. Br. J. Pharmacol. 131 : 1262 1274.
115. Gardiner, S.M., J.E. March, P.A. Kemp, et al. 2001. Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats. Br. J. Pharmacol. 132 : 1625 1629.
116. Abdelrahman, A.M. C.C Pang. 2002. Involvement of the nitric oxide/L-arginine and sympathetic nervous systems on the vasodepressor action of human urotensin II in anesthetized rats. Life Sci. 71 : 819 825.
117. Kompa, A.R., W.G. Thomas, F. See, et al. 2004. Cardiovascular role of urotensin II: effect of chronic infusion in the rat. Peptides 25 : 1783 1788.
118. Böhm, F. J. Pernow. 2002. Urotensin II evokes potent vasoconstriction in humans in vivo. Br. J. Pharmacol. 135 : 25 27.
119. Wilkinson, I.B., J.T. Affolter, S.L. De Haas, et al. 2002. High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man. Cardiovasc. Res. 53 : 341 347.
120. Leonard, A.D., J.P. Thompson, E.L. Hutchinson, et al. 2009. Urotensin II receptor expression in human right atrium and aorta: effects of ischaemic heart disease. Br. J. Anaesth. 102 : 477 484.
121. Russell, F.D., P. Molenaar D.M. O'Brien. 2001. Cardiostimulant effects of urotensin-II in human heart in vitro. Br. J. Pharmacol. 132 : 5 9.
122. Lin, Y., T. Tsuchihashi, K. Matsumura, et al. 2003. Central cardiovascular action of urotensin II in conscious rats. J. Hypertens. 21 : 159 165.
123. Lu, Y., C.J. Zou, D.W. Huang C.S. Tang. 2002. Cardiovascular effects of urotensin II in different brain areas. Peptides 23 : 1631 1635.
124. Nakayama, T., T. Hirose, K. Totsune, et al. 2008. Increased gene expression of urotensin II-related peptide in the heart of rats with congestive heart failure. Peptides 29 : 801 808.
125. Hirose, T., K. Takahashi, N. Mori, et al. 2009. Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1. Peptides 30 : 1124 1129.
126. Mori, N., T. Hirose, T. Nakayama, et al. 2009. Increased expression of urotensin II-related peptide and its receptor in kidney with hypertension or renal failure. Peptides 30 : 400 408.
127. Douglas, S.A., L. Tayara, E.H. Ohlstein, et al. 2002. Congestive heart failure and expression of myocardial urotensin II. Lancet 359 : 1990 1997.
128. Heller, J., M. Schepke, M. Neef, et al. 2002. Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension. J. Hepatol. 37 : 767 772.
129. Richards, A.M., M.G. Nicholls, J.G. Lainchbury, et al. 2002. Plasma urotensin II in heart failure. Lancet 360 : 545 546.
130. Ng, L.L., I. Loke, R.J. O'Brien, et al. 2002. Plasma urotensin in human systolic heart failure. Circulation 106 : 2877 2880.
131. Watanabe, T., R. Pakala, T. Katagiri C.R. Benedict. 2001. Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation 104 : 16 18.
132. Bousette, N., L. Patel, S.A. Douglas, et al. 2004. Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta. Atherosclerosis 176 : 117 123.
133. Maguire, J.J., R.E. Kuc, K.E. Wiley, et al. 2004. Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries. Peptides 25 : 1767 1774.
134. Hassan, G.S., S.A. Douglas, E.H. Ohlstein A. Giaid. 2005. Expression of urotensin-II in human coronary atherosclerosis. Peptides 26 : 2464 2472.
135. Segain, J.P., M. Rolli-Derkinderen, N. Gervois, et al. 2007. Urotensin II is a new chemotactic factor for UT receptor-expressing monocytes. J. Immunol. 179 : 901 909.
136. Zhang, Y.G., J. Li, Y.G. Li R.H. Wei. 2008. Urotensin II induces phenotypic differentiation, migration, and collagen synthesis of adventitial fibroblasts from rat aorta. J. Hypertens. 26 : 1119 1126.
137. Pakala R. 2008. Role of urotensin II in atherosclerotic cardiovascular diseases. Cardiovasc. Revasc. Med. 9 : 166 178.
138. Zoccali, C., F. Mallamaci, F.A. Benedetto, et al. 2008. Urotensin II and cardiomyopathy in end-stage renal disease. Hypertension 51 : 326 333.
139. Prosser, H.C.G., M.E. Forster, A.M. Richards C.J. Pemberton. 2008. Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury. Peptides 29 : 770 777.
140. Khan, S.Q., S.S. Bhandari, P. Quinn, et al. 2007. Urotensin II is raised in acute myocardial infarction and low levels predict risk of adverse clinical outcome in humans. Int. J. Cardiol. 117 : 323 328.